SMAIO

SMAIO Cash Conversion

The Cash Conversion Rate (OCF/Net Income) of SMAIO (ALSMA.PA) as of Oct 27, 2026 is -11.84 %. In the previous year, Cash Conversion Rate (OCF/Net Income) was 61.12 % — a change of -119.37% (lower).

Cash Conversion

-11.84 %

YoY

-119.37%

Last updated:

Cash Conversion Rate (OCF/Net Income) of SMAIO is 2025 -11.84 % . Cash Conversion Rate (OCF/Net Income) of SMAIO was 2024 61.12 % . It decreases by -119.37% lower compared to the previous year.

The SMAIO Cash Conversion history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Cash Conversion
Date
Cash Conversion
Jan 1, 2019
62.09 EUR
Jan 1, 2020
150.79 EUR
Jan 1, 2021
81.25 EUR
Jan 1, 2022
208.59 EUR
Jan 1, 2023
44.65 EUR
Jan 1, 2024
61.12 EUR
Jan 1, 2025
-11.84 EUR
The SMAIO Cash Conversion history
YEARCash ConversionYoY
-11.84 %-119.37%
61.12 %+36.88%
44.65 %-78.59%
208.59 %+156.73%
81.25 %-46.12%
150.79 %+142.84%
62.09 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

SMAIO Stock analysis

What does SMAIO do? S.M.A.I.O SA generates revenue through its comprehensive suite of medical devices and software solutions designed for spinal surgery. The company offers the Kheiron Spinal Fixation System, which includes implants for immobilizing and stabilizing spinal segments during fusion procedures. Its software solutions, such as i-plan, i-perform, i-check, and i-learn, provide spine surgeons with surgical planning, procedure control, outcome data analysis, and educational resources. The firm targets spine surgeons and specialists in spinal pathologies who require advanced tools for vertebral fusion procedures. The company's revenue streams include the sale of implantable devices like the Kheiron Spinal Fixation System and licensing of its software platforms, including Keops and Balance Analyzer 3D. These products are marketed to spine surgery specialists who use the clinical data and imaging tools to enhance surgical outcomes. The firm's offerings integrate software, devices, and services to address spinal pathologies requiring surgical intervention. S.M.A.I.O SA's business model focuses on delivering end-to-end solutions for spine surgery, combining hardware, software, and educational services. The Kheiron Spinal Fixation System serves as a core product for spinal immobilization, while Keops and Balance Analyzer 3D cater to surgical planning and patient data management. These products are sold directly to spine surgeons and medical specialists who rely on the company's integrated approach to improve surgical precision and patient outcomes. SMAIO is one of the most popular companies on Eulerpool.

Frequently Asked Questions about SMAIO stock

Cash Conversion Rate (OCF/Net Income) of SMAIO is -11.84 % in 2025.

Cash Conversion Rate (OCF/Net Income) of SMAIO changed from 61.12 % to -11.84 %, representing a -119.37% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Cash Conversion Rate (OCF/Net Income) SMAIO since 2006 – with annual values, charts, and detailed analysis.

Cash conversion measures how effectively net income converts to operating cash flow. Ratios above 100% indicate high-quality, cash-backed earnings.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Cash Conversion Rate (OCF/Net Income)'s SMAIO with sector peers and the industry average to assess whether it is attractive.

To evaluate Cash Conversion Rate (OCF/Net Income)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Cash Conversion Rate (OCF/Net Income).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — SMAIO

All Key Metrics — SMAIO